查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1986618

北美生物再生美容注射市場：市場規模、佔有率和趨勢分析（按產品、應用、最終用途和地區分類），細分市場預測（2026-2033 年）

North America Bioregenerative Aesthetic Injectable Market Size, Share & Trends Analysis Report By Product (PN, Peptide-based Injectables), By Application, By End Use (MedSpas, Aesthetic Surgery Centers), And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 180 Pages | 商品交期: 2-10個工作天內

價格

北美生物再生美容注射市場概述

預計到 2025 年，北美生物再生美容注射市場價值將達到 4.978 億美元，到 2033 年將達到 11.6 億美元，2026 年至 2033 年的複合年成長率為 11.2%。

這一成長是由消費者對天然、隱藏、微創的護膚療法的需求不斷成長所驅動的，這些療法能夠促進皮膚的長期健康。

富血小板血漿（PRP）、多核苷酸和外泌體等再生技術的進步正在提升這些產品的功效。全球意識的提高、可支配收入的增加以及醫療和美容基礎設施的不斷完善，進一步推動了這些產品在主要市場的普及。在美國，消費者對生物再生美容注射的需求源於對健康日益成長的關注，以及對「天然」或自體療法的強烈偏好，這些療法側重於組織修復而非僅僅遮蓋瑕疵。高所得的都市區專業人士將美容療程視為自我護理的一部分，因此這些療法的普及率最高。

他們更傾向於微創、可重複的療程，例如富血小板血漿（PRP）、胜肽類增效劑和外泌體增效劑。診所的療效、病患口碑以及社群媒體上的意見領袖都會影響他們的選擇。強調再生、癒合和生物製劑的訊息能夠引起那些對合成植入持謹慎態度，但願意投資於長期皮膚健康的人們的共鳴。在美國，對微創注射療法的需求持續成長。專家數據顯示，這些療程的數量略有上升，全球調查顯示，美國在美容手術總量方面位居世界第一，這表明美國此類療程供應充足，且患者對其較為熟悉。

龐大的勞動年齡人口是聚乳酸（PLLA）填充劑需求的主要驅動力。根據加拿大統計局（2024年9月）的數據，加拿大的中位數年齡為40.3歲，20至65歲之間的人群中有相當一部分正在積極尋求解決皺紋、皮膚鬆弛和容量流失等問題的方法。 PLLA填充劑是這群人的首選，因為它能刺激體內膠原蛋白的合成，帶來漸進且自然的改善效果。同時，根據美國人口普查局（2023年5月）的數據，美國老年人口（約佔65歲以上人口的六分之一）也越來越傾向於尋求再生美容解決方案來對抗與老齡化相關的皮膚變化，這進一步推動了市場成長。此外，美國擁有世界上最高的整形外科醫生密度之一，注射類產品的普及程度也很高，這進一步增強了該市場的成長潛力。

與美國患者相比，加拿大患者在使用生物再生注射療法時往往更為謹慎。他們的決定主要受皮膚科醫生和整形外科醫生等臨床醫生的指導，這些醫生通常透過轉診獲得。此外，加拿大社會對醫療合法性的認知也更為嚴格，這也會影響他們的決定。由於許多加拿大人依賴全民健保系統進行基層醫療保健，因此選擇性美容手術大多屬於自願性質，需要自費，並且主要在多倫多、溫哥華和蒙特利爾等都市區進行，因為這些地區集中了專業的診所和皮膚科醫生。

儘管富血小板血漿（PRP）等再生醫學療法已逐漸普及，但由於其監管存在地域差異（例如，加拿大衛生署負責監管自體血液製品），因此人們對明確的安全性和有效性證據的需求日益成長。在這種法規環境下，患者往往更傾向於選擇由診所主導、以實證醫學為基礎的治療方案，而非盲目追隨社群媒體上的趨勢。因此，先進的再生醫學注射技術正緩慢但穩定地推廣應用，患者在選擇外泌體和肽類療法時，會優先考慮醫生的聲譽、已發表的證據以及透明的安全措施。

目錄

第1章：分析方法和範圍

第2章執行摘要

第3章：北美生物再生美容注射市場：影響因素、趨勢和範圍

  • 市場歷史及展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
  • 北美生物再生美容注射市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL 分析
  • 生物再生美容注射市場概況（北美市場規模（估計值），按地區分類，2025 年）
  • 消費行為分析
  • 從業者/服務提供者展望
    • 預計各國美容注射產品專業人員及供應商數（2024/25 年及以後）
    • 提供注射治療的前 3-5 名的專家：按國家/地區分類

第4章：北美生物再生美容注射市場：按產品分類的估算與趨勢分析

  • 北美生物再生美容注射市場：產品概覽
  • 北美生物再生美容注射市場：按產品分類的波動分析（2021-2033 年）
  • 北美生物再生美容注射市場：按產品分類的收入（2021-2033 年）
  • PN
    • PDRN
    • PN注射
  • 基於胜肽的注射藥物
  • 基於外泌體的注射藥物
  • 生物促效劑注射
    • PLLA
    • CaHA
  • PRP製備
  • 其他

第5章：北美生物再生美容注射市場：按應用分類的估算和趨勢分析

  • 北美生物再生美容注射市場：產品概覽
  • 北美生物再生美容注射市場：按應用領域分類的波動分析（2021-2033 年）
  • 北美生物再生美容注射市場估計與預測：按應用領域分類的收入（2021-2033 年）
  • 肌膚補水保濕（臉部）
  • 彈性和緊緻度（臉部）
  • 眼部區域（臉部）
  • 細紋（臉部）
  • 痤瘡疤痕（臉部）
  • 改善臉部皺紋
  • 身體護理
    • 手臂和大腿
    • 低胸裝
    • 敏感區域
    • 膝蓋
    • 頭皮和頭髮再生

第6章：北美生物再生美容注射市場：按最終用途分類的估算和趨勢分析

  • 北美生物再生美容注射市場：按最終用途分類的概覽
  • 北美生物再生美容注射市場：按最終用途分類的波動分析（2021-2033 年）
  • 北美生物再生美容注射市場估計與預測：按最終用途分類的收入（2021-2033 年）
  • 醫療水療中心
  • 整形外科中心
  • 醫院
  • 皮膚病中心
  • 其他

第7章：北美生物再生美容注射市場：區域估算和趨勢分析（按產品、應用和最終用途分類）

  • 區域儀錶板
  • 市場規模、預測與趨勢分析（2021-2033）
  • 北美洲
    • 美國
    • 加拿大

第8章 競爭情勢

  • 公司/競爭對手分類
  • 供應商情況
    • 主要經銷商和通路合作夥伴名單
    • 主要企業市佔率分析（2025 年）
    • PharmaResearch Products Co., Ltd.
    • MD Skin Solutions
    • Mastelli srl
    • Merz Aesthetics
    • Caregen Co. Ltd
    • Croma Pharma
    • PROMOITALIA
    • Galderma
    • Fillmed
    • IBSA
    • Bio-Formula
    • BR Pharma
    • Allergan（AbbVie）
    • Merz
    • Fidia
    • VAIM
Product Code: GVR-4-68040-850-1

North America Bioregenerative Aesthetic Injectable Market Summary

The North America bioregenerative aesthetic injectable market size was estimated at USD 497.8 million in 2025 and is projected to reach USD 1,160.0 million by 2033, growing at a CAGR of 11.2% from 2026 to 2033. This growth is driven by rising consumer demand for natural-looking, minimally invasive treatments that promote long-term skin health.

Advances in regenerative technologies like platelet-rich plasma, polynucleotides, and exosomes are boosting product effectiveness. Increasing awareness, higher disposable incomes, and expanding medical aesthetics infrastructure worldwide are further driving adoption across key markets. In the U.S., consumer behavior toward bioregenerative aesthetic injectables is driven by a wellness focus and a strong preference for "natural" or autologous options that emphasize tissue repair rather than merely hiding imperfections. Adoption is highest among urban professionals in higher-income brackets who view aesthetic treatments as part of their self-care routine.

They prefer minimally invasive procedures that can be repeated, such as PRP, peptide-based boosters, and exosome boosters. Clinic results, patient reviews, and social media influencers shape their choices. Messaging highlights regeneration, healing, and biologics, resonates with those cautious about synthetic implants yet willing to spend on long-term skin health. The U.S. continues to see growth in minimally invasive injectables. Professional data show a slight increase in these treatments, and global surveys rank the U.S. as the leader in total aesthetic procedures, indicating a strong supply and patient familiarity.

The prevalent working-age population significantly fuels the demand for PLLA fillers. According to Statistics Canada (September 2024), the median age in Canada is 40.3 years, with a substantial portion aged 20-65 actively seeking solutions to address wrinkles, sagging, and volume loss. PLLA fillers provide gradual, natural-looking improvements by stimulating endogenous collagen synthesis, making them a favorable option for this demographic. In parallel, the U.S. geriatric population, approximately 1 in 6 individuals above 65, as per the U.S. Census Bureau (May 2023), increasingly seeks regenerative aesthetic solutions to counteract age-related skin changes, further propelling market growth. The U.S. also has the highest concentration of plastic surgeons globally, creating widespread access to advanced injectables and reinforcing the market's expansion potential.

Canadian patients tend to use bioregenerative injectables more cautiously than their U.S. counterparts. Their decisions are mainly guided by clinicians, such as dermatologists and plastic surgeons, recommended through referrals and influenced by stricter public perceptions of medical legitimacy. Since many Canadians rely on a universal health system for primary care, elective aesthetic procedures are largely discretionary, paid out-of-pocket, and mainly performed in urban areas like Toronto, Vancouver, and Montreal, where specialist clinics and dermatologists are concentrated.

Popular regenerative treatments like PRP are well-established, but they are regulated locally (Health Canada oversees autologous blood products), which increases the demand for clear safety and effectiveness evidence. This regulatory environment encourages patients to prefer clinic-led, evidence-supported treatments over social-media trends. As a result, the adoption of advanced regenerative injectables occurs more slowly but consistently, with patients emphasizing physician reputation, published evidence, and transparent safety measures when selecting exosome or peptide therapies.

North America Bioregenerative Aesthetic Injectable Market Report Segmentation

This report forecasts revenue growth at regional and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the North America bioregenerative aesthetic injectable market report based on product, application, end use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • PN
    • PDRN
    • PN Injectables
  • Peptide-based Injectables
  • Exosome-based Injectables
  • Biostimulatory Injectables
    • PLLA
    • CaHA
  • PRP Injectables
  • Others
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Skin Hydration & Moisturization (For Face)
  • Elasticity & Firmness (For Face)
  • Under eye-areas (For Face)
  • Fine Lines (For Face)
  • Acne Scar (For Face)
  • Wrinkle Correction (For Face)
  • Body Application
    • Arms & Thighs
    • Decolletage
    • Intimate Areas
    • Knees
    • Scalp & Hair Rejuvenation
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • MedSpas
  • Aesthetic Surgery Centers
  • Hospitals
  • Dermatology Centers
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Application Outlook
    • 2.2.3. End Use Outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. North America Bioregenerative Aesthetic Injectable Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. North America Bioregenerative Aesthetic Injectable Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
  • 3.4. Topline Overview of the Bioregenerative Aesthetic Injectable Market (Market Size, by Region, Topline Estimated for North America, 2025)
  • 3.5. Consumer Behavior Analysis
  • 3.6. Practitioner/Provider Outlook
    • 3.6.1. Estimated Number of Professionals/ Providers Administering Aesthetic Injectable Product by Country, for 2024/25-
      • 3.6.1.1. U.S.
      • 3.6.1.2. Canada
    • 3.6.2. Three to Five Key Professionals Offering an Injectable Procedure, by Country-
      • 3.6.2.1. U.S.
      • 3.6.2.2. Canada

Chapter 4. North America Bioregenerative Aesthetic Injectable Market: Product Estimates & Trend Analysis

  • 4.1. North America Bioregenerative Aesthetic Injectable Market: Product Dashboard
  • 4.2. North America Bioregenerative Aesthetic Injectable Market: Product Movement Analysis, 2021 to 2033 (USD Million)
  • 4.3. North America Bioregenerative Aesthetic Injectable Market by Product, Revenue, 2021 to 2033 (USD Million)
  • 4.4. PN
    • 4.4.1. PN market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. PDRN
      • 4.4.2.1. PDRN market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. PN Injectable
      • 4.4.3.1. PN injectable market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.5. Peptide-based Injectables
    • 4.5.1. Peptide-based injectables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.6. Exosome-based injectables
    • 4.6.1. Exosome-based injectables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.7. Biostimulatory Injectables
    • 4.7.1. Biostimulatory injectables market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.2. PLLA
      • 4.7.2.1. PLLA market estimates and forecasts, 2021 - 2033 (USD Million)
    • 4.7.3. CaHA
      • 4.7.3.1. CaHA market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.8. PRP Injectables
    • 4.8.1. PRP Injectables market estimates and forecasts, 2021 - 2033 (USD Million)
  • 4.9. Others
    • 4.9.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. North America Bioregenerative Aesthetic Injectable Market: Application Estimates & Trend Analysis

  • 5.1. North America Bioregenerative Aesthetic Injectable Market: Application Dashboard
  • 5.2. North America Bioregenerative Aesthetic Injectable Market: Application Movement Analysis, 2021 to 2033 (USD Million)
  • 5.3. North America Bioregenerative Aesthetic Injectable Market Estimates and Forecasts, By Application, Revenue, 2021 to 2033 (USD Million)
  • 5.4. Skin Hydration & Moisturization (For Face)
    • 5.4.1. Skin Hydration & Moisturization (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.5. Elasticity & Firmness (For Face)
    • 5.5.1. Elasticity & Firmness (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.6. Under eye-areas (For Face)
    • 5.6.1. Under eye-areas (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.7. Fine Lines (For Face)
    • 5.7.1. Fine Lines (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.8. Acne Scar (For Face)
    • 5.8.1. Acne Scar (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.9. Wrinkle Correction (For Face)
    • 5.9.1. Wrinkle Correction (For Face) market estimates and forecasts for 2021 - 2033 (USD Million)
  • 5.10. Body Application
    • 5.10.1. Body Application market estimates and forecasts for 2021 - 2033 (USD Million)
    • 5.10.2. Arms & Thighs
      • 5.10.2.1. Arms & Thighs market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.3. Decolletage
      • 5.10.3.1. Decolletage market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.4. Intimate Areas
      • 5.10.4.1. Intimate Areas market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.5. Knees
      • 5.10.5.1. Knees market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.10.6. Scalp & Hair Rejuvenation
      • 5.10.6.1. Scalp & Hair Rejuvenation market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. North America Bioregenerative Aesthetic Injectable Market: End Use Estimates & Trend Analysis

  • 6.1. North America Bioregenerative Aesthetic Injectable Market: End Use Dashboard
  • 6.2. North America Bioregenerative Aesthetic Injectable Market: End Use Movement Analysis, 2021 to 2033 (USD Million)
  • 6.3. North America Bioregenerative Aesthetic Injectable Market Estimates and Forecasts, By End Use, Revenue, 2021 to 2033 (USD Million)
  • 6.4. MedSpas
    • 6.4.1. MedSpas market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.5. Aesthetic Surgery Centers
    • 6.5.1. Aesthetic Surgery Centers market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.6. Hospitals
    • 6.6.1. Hospitals market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.7. Dermatology Centers
    • 6.7.1. Dermatology Centers market estimates and forecasts for 2021 - 2033 (USD Million)
  • 6.8. Others
    • 6.8.1. Others market estimates and forecasts for 2021 - 2033 (USD Million)

Chapter 7. North America Bioregenerative Aesthetic Injectable Market: Regional Estimates & Trend Analysis by Product, Application, and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
      • 7.3.1.5. Key Cosmetic Polynucleotides Brands Available in the U.S. (This analysis is specific to the U.S. only)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. List of key distributors and channel partners
    • 8.2.2. Key company market share analysis, 2025
    • 8.2.3. PharmaResearch Products Co., Ltd.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. MD Skin Solutions
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Mastelli s.r.l.
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Merz Aesthetics
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Caregen Co. Ltd
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Croma Pharma
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. PROMOITALIA
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Galderma
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives
    • 8.2.11. Fillmed
      • 8.2.11.1. Company overview
      • 8.2.11.2. Financial performance
      • 8.2.11.3. Product benchmarking
      • 8.2.11.4. Strategic initiatives
    • 8.2.12. IBSA
      • 8.2.12.1. Company overview
      • 8.2.12.2. Financial performance
      • 8.2.12.3. Product benchmarking
      • 8.2.12.4. Strategic initiatives
    • 8.2.13. Bio-Formula
      • 8.2.13.1. Company overview
      • 8.2.13.2. Financial performance
      • 8.2.13.3. Product benchmarking
      • 8.2.13.4. Strategic initiatives
    • 8.2.14. BR Pharma
      • 8.2.14.1. Company overview
      • 8.2.14.2. Financial performance
      • 8.2.14.3. Product benchmarking
      • 8.2.14.4. Strategic initiatives
    • 8.2.15. Allergan (AbbVie)
      • 8.2.15.1. Company overview
      • 8.2.15.2. Financial performance
      • 8.2.15.3. Product benchmarking
      • 8.2.15.4. Strategic initiatives
    • 8.2.16. Merz
      • 8.2.16.1. Company overview
      • 8.2.16.2. Financial performance
      • 8.2.16.3. Product benchmarking
      • 8.2.16.4. Strategic initiatives
    • 8.2.17. Fidia
      • 8.2.17.1. Company overview
      • 8.2.17.2. Financial performance
      • 8.2.17.3. Product benchmarking
      • 8.2.17.4. Strategic initiatives
    • 8.2.18. VAIM
      • 8.2.18.1. Company overview
      • 8.2.18.2. Financial performance
      • 8.2.18.3. Product benchmarking
      • 8.2.18.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America bioregenerative aesthetic injectable market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America bioregenerative aesthetic injectable market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America bioregenerative aesthetic injectable market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America bioregenerative aesthetic injectable market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. bioregenerative aesthetic injectable market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. bioregenerative aesthetic injectable market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. bioregenerative aesthetic injectable market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada bioregenerative aesthetic injectable market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada bioregenerative aesthetic injectable market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada bioregenerative aesthetic injectable market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market research approaches
  • Fig. 4 QFD modeling for market share assessment
  • Fig. 5 Market formulation & validation
  • Fig. 6 North America Bioregenerative Aesthetic Injectable Market: Market Outlook
  • Fig. 7 North America Bioregenerative Aesthetic Injectables Competitive Insights
  • Fig. 8 Parent market outlook
  • Fig. 9 Related/ancillary market outlook
  • Fig. 10 North America Bioregenerative Aesthetic Injectable Market Driver Impact
  • Fig. 11 North America Bioregenerative Aesthetic Injectable Market Restraint Impact
  • Fig. 12 North America Bioregenerative Aesthetic Injectable Market: Product movement analysis
  • Fig. 13 North America Bioregenerative Aesthetic Injectable Market: Product outlook and key takeaways
  • Fig. 14 PN market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 15 PDRN market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 16 PN injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 17 Peptide-based injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 18 Exosome-based injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 19 Biostimulatory injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 20 PLLA market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 21 CaHA lens market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 22 PRP injectables market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 23 Other market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 24 North America Bioregenerative Aesthetic Injectable Market: Application movement analysis
  • Fig. 25 North America Bioregenerative Aesthetic Injectable Market: Application outlook and key takeaways
  • Fig. 26 Skin hydration & moisturization (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 27 Elasticity & firmness (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 28 Under eye-areas (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 29 Fine lines (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 30 Acne scar (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 31 Wrinkle correction (For Face) market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 32 Body application market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 33 Arms & thighs market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 34 Decolletage market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 35 Intimate areas market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 36 Knees market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 37 Scalp & hair rejuvenation market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 38 North America Bioregenerative Aesthetic Injectable Market: End Use movement analysis
  • Fig. 39 North America Bioregenerative Aesthetic Injectable Market: End Use outlook and key takeaways
  • Fig. 40 MedSpas market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 41 Aesthetic surgery centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 42 Hospitals market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 43 Dermatology centers market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 44 Others market estimates and forecast, 2021 - 2033 (USD Million)
  • Fig. 45 North America Bioregenerative Aesthetic Injectable Market: Regional movement analysis
  • Fig. 46 North America Bioregenerative Aesthetic Injectable Market: Regional outlook and key takeaways
  • Fig. 47 North America Bioregenerative Aesthetic Injectable Market share and leading players
  • Fig. 48 North America, by country
  • Fig. 49 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 U.S. key country dynamics
  • Fig. 51 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Canada key country dynamics
  • Fig. 53 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Market share of key market players- Bioregenerative Aesthetic Injectable Market